Efficacy and safety of adjunctive bitopertin (5 and 10mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the phase III DayLyte study

✍ Scribed by Arango, Celso; Nasrallah, Henry; Lawrie, Stephen; Lohmann, Tania Ochi; Zhu, Jon Luca; Garibaldi, George; Wang, Alice; Bugarski-Kirola, Dragana

• Book ID: 126547808
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 133 KB
• Volume: 158
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/j.schres.2014.07.038